Vivo Capital, LLC Calliditas Therapeutics Ab Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.03 - $33.19 $1.31 Million - $2.07 Million	-62,306 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$26.02 - $31.17 $6.47 Million - $7.75 Million	-248,724 Reduced 79.97%	62,306 $1.84 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $36.65 $6.28 Million - $9.86 Million	-268,970 Reduced 46.37%	311,030 $10.5 Million
Q2 2020 Aug 14, 2020	BUY	$19.17 - $23.2 $11.1 Million - $13.5 Million	580,000 New	580,000 $13.5 Million

827K

8.5K

26.6K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.